InsidersTradesSigma
Lexaria Bioscience Corp.: insider trades · United States · SEC (Form 4)
SEC:lexaria-bioscience-corp-a67fdcUS·SEC (Form 4)Mcap 14M€Healthcare
Discover the full management transaction log of Lexaria Bioscience Corp., a publicly traded company based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Operating in the Healthcare sector, Lexaria Bioscience Corp. has recorded 3 insider filings. Market capitalisation: €14.4m. The latest transaction was reported on 25 May 2022 (Attribution). Among the most active insiders: REESE ALBERT L JR. Every trade is accessible without an account.
3
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended August 2025 · cache
0.58 €
Analyst consensus
2 analysts1.50 €Target 3.75 €(+547%)6.00 €
Income statement
Revenue706 k€
Gross profit703 k€100% margin
Net income−11.9 M€-1686.0% margin
Valuation
P/Book2.2x
Beta0.36
Balance sheet & cash
Market cap14.4 M€
Total debt109 k€
Free Cash Flow−10.6 M€
Debt / Equity2%
Profitability & ownership
ROE-147.1%
ROA-76.0%
% insiders5.7%
% institutions6.0%
Last declaration on 25 May 2022
Declarations3 total
Executives◆Grant37SEC
€9,1185,000 shares@ €1.82370.063% mcap57.7% of flow
common shares
SEC:0001855763-22-000006:0·
Executives◆Grant17SEC
€3,4131,799 shares@ €1.89720.024% mcap21.6% of flow
common shares
SEC:0001855763-22-000005:0·
Executives◆Grant17SEC
€3,2601,700 shares@ €1.91740.023% mcap20.6% of flow
common shares
SEC:0001855763-22-000004:0·
3 of 3 declarations